The case for routine patient review in long COVID research
Signup-walled: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00134-9/abstract
(As in it says you can simply sign in with a Lancet account and read it)
Long COVID is an infection-associated chronic condition that occurs after SARS-CoV-2 infection and can lead to sometimes severe disability.1–3 In early 2024, long COVID had already affected 400 million people, with an estimated annual global economic impact of US$1 trillion.2 6 years into the COVID-19 pandemic, research into long COVID has progressed considerably, and evidence implicates several pathomechanisms, including aberrant immunity, persistent pathogens, endothelial dysfunction, and mitochondrial dysfunction.1–3 People with long COVID have played a crucial role in the field's development, establishing long COVID as a disease entity in the scientific literature4,5 and publishing numerous articles on epidemiology, public health, pathomechanisms, and trial design—two of which are among the ten most cited in the field.1,5
Signup-walled: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00134-9/abstract
(As in it says you can simply sign in with a Lancet account and read it)
Long COVID is an infection-associated chronic condition that occurs after SARS-CoV-2 infection and can lead to sometimes severe disability.1–3 In early 2024, long COVID had already affected 400 million people, with an estimated annual global economic impact of US$1 trillion.2 6 years into the COVID-19 pandemic, research into long COVID has progressed considerably, and evidence implicates several pathomechanisms, including aberrant immunity, persistent pathogens, endothelial dysfunction, and mitochondrial dysfunction.1–3 People with long COVID have played a crucial role in the field's development, establishing long COVID as a disease entity in the scientific literature4,5 and publishing numerous articles on epidemiology, public health, pathomechanisms, and trial design—two of which are among the ten most cited in the field.1,5